Veeva Systems (VEEV.US) Price Target and Rating 2026/2027

323.04
Share this analysis:

Veeva Systems Price Target 2026: Analysts See 8% Downside

The average price target for Veeva Systems is $298.70. This price target represents the analysts' view of the stock price over the next 12 months. The stock appears overvalued, because the price target is lower than the current price. It is -7.53% above the target, and analysts expect the price to fall over the next 12 months. Even if the stock may be overvalued, price momentum can last longer than expected. That is why it is important to keep an eye on the stock and its momentum on an ongoing basis. WallStreetBuys helps you with the technical analysis and keeps you up to date on the development.
⚠️ Don’t buy a stock just because of its price targetA price target is the analysts’ estimate of where the stock will trade in 12 months. That estimate is often wrong. A large study of US stocks from 2000 to 2009 found that only 38% of price targets had been met after 12 months. On average, the targets promised 15 percentage points more return than the stocks delivered. Use the price target together with the financials and the trend, not on its own.Source: Bradshaw, Brown and Huang (2013)

Is Veeva Systems overvalued or undervalued?

Veeva Systems is currently fairly valued with a gap of 7.5% relative to the price target.


The current price is $323.04, which places Veeva Systems in the fairly valued category. The stock is considered undervalued when the price is below $268.83, and overvalued when the price exceeds $328.57.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Veeva Systems, the fair value range lies between $268.83 and $328.57.


See the full price target analysis for Veeva Systems →

Analyst Ratings for Veeva Systems stock in 2026: Buy

29 analysts cover Veeva Systems. The majority is positive, with 68.9% recommending Buy, while 27.6% recommend Hold. The average price target is $298.70, which is 7.5% below the current price.

Consensus: Buy (4.07/5)
Strong Buy
13 (44.8%)
Buy
7 (24.1%)
Hold
8 (27.6%)
Strong Sell
1 (3.4%)
Strong Sell Sell Hold Buy Strong Buy
4.07 out of 5 based on 29 analysts

About Veeva Systems – Health Information Services

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California. Read more about the company

Key Figures for Veeva Systems

$52.2B Market cap
$3.5B Revenue
Health Information Services Industry
52.53 P/E
15.10 P/S
5.90 P/B
United States Listed on exchange
veeva.com Website

What kind of stock is Veeva Systems?

Growth stock Momentum stock

Veeva Systems is classified as a growth stock and momentum stock. This means the stock combines several attractive traits, and strong price momentum.

Score Overview for Veeva Systems

💰 Value Score 15/100 (Very Low)
⭐ Quality Score 71/100 (High)
🚀 Momentum Score 99/100 (Very High)
📊 Total Score 61/100

📈 Valuation

Veeva Systems trades at a P/E ratio of 52.5, which is above the market average. The forward P/E is 30.2 (42% lower), which suggests the market expects rising earnings. The P/S ratio is 15.1 (high — the market pays a premium for the revenue). The P/B ratio is 5.9. The PEG ratio is 1.21.

💵 Profitability & Growth

Veeva Systems has a profit margin of 29.3% (excellent) and an operating margin of 29.6%. Return on equity (ROE) is 14.4% — solid return on equity. Return on assets (ROA) is 7.6%. The latest quarterly earnings grew 39.5% year over year — strong growth.

🏦 Financial Health

The Piotroski score is 5 out of 9 — average financial health. Altman Z2 is 12.18 (healthy balance sheet — low risk). The debt-to-equity ratio (D/E) is 25.8% — low debt, a solid balance sheet.

🚀 Momentum & Short Interest

Short interest is 3.31%.

Insider Trading in Veeva Systems 2026: Only sells

In 2026, insiders at Veeva Systems have made 20 transactions, all of which were sales. On a net basis, insiders took $14,053,379 out of the stock. Active insiders include Faddis Jonathan, Rizzo Daniel J, Schwenger Thomas D. and others. Over the last 3 months: only sells.

Last 3 Months: Only sells

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 6 sales. A net $5,821,917 out of the stock.

All Transactions: Only sells

Insiders have exclusively sold shares in the recent period. This can suggest management sees limited opportunity.

Across the last 20 transactions: 0 purchases and 20 sales. A net $14,053,379 out of the stock.

Latest sale: Faddis Jonathan sold 3,515 shares at $298.19 each on 2026-10-14.

Who is selling: Faddis Jonathan, Rizzo Daniel J, Schwenger Thomas D., Hung Priscilla, Zuppas Eleni Nitsa and others.

Latest Insider Trades in Veeva Systems (2026)

The table shows the last 20 reported insider transactions in Veeva Systems. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-10-14 Faddis Jonathan Sell 3,515 298 1,048,138
2026-10-02 Rizzo Daniel J Sell 4,520 276 1,248,469
2026-09-14 Schwenger Thomas D. Sell 1,000 265 265,200
2026-09-09 Hung Priscilla Sell 750 261 195,780
2026-08-27 Schwenger Thomas D. Sell 10,000 281 2,813,300
2026-08-13 Schwenger Thomas D. Sell 1,000 251 251,030
2026-07-16 Schwenger Thomas D. Sell 5,000 200 1,000,000
2026-04-30 Hung Priscilla Sell 750 156 116,730
2026-04-10 Hung Priscilla Sell 750 154 115,125
2026-03-05 Schwenger Thomas D. Sell 1,000 200 200,000

Who is buying and selling Veeva Systems shares in 2026?

The following insiders have sold shares: Faddis Jonathan, Rizzo Daniel J, Schwenger Thomas D., Hung Priscilla, Zuppas Eleni Nitsa and others. In total, $14,053,379 was sold across 20 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Veeva Systems Short Selling 2026: 3.3% Sold Short

Moderate short interest: 3.3% of the free float
Short % of free float
3.3%
Assessment
Moderate short interest
Short squeeze risk
Low
Data source
EODHD
Reported about twice a month
The stock has a moderate share of short selling. Between 2-5% of the freely traded shares are sold short, which is within the normal range for most stocks.

Short interest comes from our data provider EODHD. The figure is reported about twice a month; we check it every trading day.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
▲
3.3%

When Does Veeva Systems Report Earnings – Next Date: Nov 19, 2026

The next earnings report from Veeva Systems is scheduled for November 19, 2026. This report covers the fourth quarter (Q4), which ended on October 31, 2026.



Technical Analysis of Veeva Systems 2026 – Signal: Strong Buy

Overall Technical Signal: Strong Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated October 24, 2026.

Trend Analysis of Veeva Systems Inc

Veeva Systems Inc is in a short-term uptrend. The price of $323.04 is 8.6% above the 20-day average ($297.47). Medium term, the picture is positive: the price is 16.7% above the 50-day average ($276.93). Long term, the stock is 55.9% above the 200-day average ($207.17), which confirms a long-term uptrend.

Golden Cross: The 50-day average (276.93) is above the 200-day average (207.17), which is a classic bullish signal for Veeva Systems Inc.

Is Veeva Systems Inc overbought or oversold?

Veeva Systems Inc has an RSI of 76.2, which places the stock in overbought territory (above 70). Even though the stock is overbought, the broader trend is positive. A short-term pullback is possible, but the trend still supports the price.

MACD Analysis for Veeva Systems Inc

Daily MACD: MACD is positive (14.485), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (12.533) by 1.952, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is positive (28.437), which indicates a broader bullish long-term trend. MACD5 is above the signal line (17.557) by 10.880, which confirms rising long-term momentum.

Overall MACD assessment: Both the daily and weekly MACD are positive and above their signal lines. Trend and momentum confirm each other across time horizons – the strongest bullish signal.

Risk Profile for Veeva Systems Inc

Veeva Systems Inc has an annual standard deviation of 43.1%, which classifies the stock as medium risk. The price can swing noticeably when the market moves.

Overall Technical Conclusion for Veeva Systems Inc

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (14.485). Weekly bullish (28.437).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 76.2 – overbought.

Technical signal: Strong Buy

The price is in an uptrend (above SMA50/SMA200) and MACD is positive on both a daily and weekly basis. Trend and MACD trend confirm each other – the strongest technical buy signal.

Frequently Asked Questions About Veeva Systems stock in 2026

Should you buy Veeva Systems stock now?
Yes, the technical signal for Veeva Systems is currently Strong Buy. Veeva Systems trades at $323.04 as of Oct 24, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 14.485 with rising momentum (signal: 12.533); RSI is at 76.2 (overbought), suggesting the price may have risen too quickly; the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $298.70 is 7.5% below the current price. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Veeva Systems stock?
The average analyst price target for Veeva Systems is $298.70. The current price is $323.04, which gives a downside of 7.5%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $268.83 and $328.57.
Is Veeva Systems a dividend stock?
No, Veeva Systems does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Veeva Systems stock?
Veeva Systems is rated as a stock in the risk category Moderate. the annual standard deviation is 43.1%, which classifies the stock as Moderate. In addition, an RSI of 76.2 signals overbought (elevated risk of a pullback).
Is Veeva Systems overvalued?
Veeva Systems is considered fairly valued – the price is close to the analyst price target. Veeva Systems has the following valuation ratios: a P/E ratio of 52.5 (highly valued), a P/S ratio of 15.1, a P/B ratio of 5.9. The stock trades close to the analyst price target and is considered fairly valued.
Is Veeva Systems overbought?
Yes, Veeva Systems is overbought with an RSI of 76.2 (above 70). The technical indicators show: RSI is at 76.2 (above the 70 mark), which signals the price is overbought and may have risen too quickly. In addition, the price is 8.6% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Veeva Systems earnings report?
Veeva Systems reports its next earnings on November 19, 2026. The stock currently trades at $323.04. With a P/E ratio of 52.5, the market will be watching closely whether earnings meet expectations. The RSI is at 76.2, so the report can reinforce the current technical trend.
Is Veeva Systems shorted?
Yes, Veeva Systems is shorted with 3.3% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Veeva Systems stock?
No, insiders are not buying Veeva Systems shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 6 sales. On a net basis, 5,821,917 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 14,053,379 $ sold. Active sellers include Faddis Jonathan, Rizzo Daniel J, Schwenger Thomas D. and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Veeva Systems a good stock?
Based on our total score, Veeva Systems is rated as a good stock with a total score of 61 out of 100. The stock scores above average on value, quality and momentum. The score is made up of Value: 15/100, Quality: 71/100, Momentum: 99/100. Whether now is the time to buy is a separate question: the technical signal is Strong Buy. Whether Veeva Systems is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Veeva Systems stock?
The outlook for Veeva Systems based on current data: the average analyst price target is $298.70 (-7.5%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on Nov 19, 2026, which can move the price; the P/E ratio is 52.5 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Veeva Systems stock rising?
Veeva Systems is rising right now. The technical indicators show: the price is 8.6% above the 20-day average; MACD is positive with rising momentum (bullish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Veeva Systems go?
The average analyst price target for Veeva Systems is $298.70, which is 7.5% below the current price of $323.04. The stock has traded between $148.05 and $325.99 over the last 52 weeks. The price is close to the 52-week high. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Veeva Systems fall?
The stock has traded as low as $148.05 over the last 52 weeks — that is 54.2% below the current price of $323.04. The biggest decline (drawdown) in the same period was 54.6% from high to low. Within a year, the price typically swings about ±43.1% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Veeva Systems do?
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnolo... The company belongs to the Healthcare sector, more specifically the Health Information Services industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Veeva Systems as an investment.
Did Veeva Systems raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Veeva Systems. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Veeva Systems making money or losing money?
Yes, Veeva Systems is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 29.3% — which is excellent. The operating margin (profit before interest and taxes) is 29.6%. At a P/E ratio of 52.5, you currently pay 52.5 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Veeva Systems go bankrupt?
The bankruptcy risk of Veeva Systems is rated as low. Altman Z2 (a model for assessing financial distress) is 12.18 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 26% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Veeva Systems have a lot of debt?
No, Veeva Systems has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 26%. For the healthcare sector, anything below 80% counts as low debt. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.

Other Stocks in Healthcare

Compare Veeva Systems with other stocks in the healthcare sector. Click a stock to see its technical analysis, insider trading and key figures.

See all 111 stocks in the Healthcare sector